chr13-29480218-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001033602.4(MTUS2):c.3253G>A(p.Glu1085Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000271 in 1,402,856 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001033602.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MTUS2 | NM_001033602.4 | c.3253G>A | p.Glu1085Lys | missense_variant | 10/16 | ENST00000612955.6 | NP_001028774.3 | |
MTUS2-AS1 | NR_046378.1 | n.690-3279C>T | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MTUS2 | ENST00000612955.6 | c.3253G>A | p.Glu1085Lys | missense_variant | 10/16 | 5 | NM_001033602.4 | ENSP00000483729 | ||
MTUS2-AS1 | ENST00000323380.7 | n.1568-3279C>T | intron_variant, non_coding_transcript_variant | 5 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.0000380 AC: 6AN: 157834Hom.: 0 AF XY: 0.0000357 AC XY: 3AN XY: 83984
GnomAD4 exome AF: 0.0000271 AC: 38AN: 1402856Hom.: 1 Cov.: 30 AF XY: 0.0000376 AC XY: 26AN XY: 692224
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 31, 2024 | The c.3283G>A (p.E1095K) alteration is located in exon 8 (coding exon 8) of the MTUS2 gene. This alteration results from a G to A substitution at nucleotide position 3283, causing the glutamic acid (E) at amino acid position 1095 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at